Ghaith Abu-Zeinah, MD

Weill Cornell Medicine
Division of Hematology and Oncology, Department of Medicine and the Richard T. Silver Center Myeloproliferative Neoplasms Center
520 E 70th street
Starr 341
New York, NY
USA 10065
4316 Initial Therapy of Polycythemia Vera (PV) with Interferon Alfa (rIFNa) Compared to Hydroxyurea (HU) or Phlebotomy Only (PHL-O) Is Associated with a Lower Risk of Secondary Myelofibrosis
4317 Myeloproliferative Neoplasm (MPN) Driver Mutations Are Enriched during Hematopoietic Stem Cell Differentiation in Patterns That Correlate with Clinical Phenotype and Treatment Response